And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...
Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for ...
Papcemias FDA Approval -- Granted full FDA approval in August with the first and only available treatment for all adults with recurrent respiratory papillomatosis (RRP); label is broad with no ...
Ezra Klein and Aaron Retica discuss whether affordability is the Democrats’ winning message, Trump’s politics of cruelty and ...
Most patients with sickle cell disease who go to the ED for vaso-occlusive crises do not get triaged according to guideline ...
Listen to the morning keynote session with Reddit's Jess Calef from the 2025 MM+M Media Summit. The pair underscore why the ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) Q3 2025 Earnings Call Transcript November 12, 2025 Acumen Pharmaceuticals, Inc.
Cynata Therapeutics Limited ( OTCPK:CYYNF) Discusses Clinical Trial Progress and Corporate Developments Including GVHD, Osteoarthritis, and Kidney Transplantation November 5, 2025 8:30 PM EST ...
Thank you, operator. Hello, and welcome, everyone. Today's earnings call will be led by Dr. Samantha Du, Zai Lab's Founder, CEO and Chairperson. She will be joined by Josh Smiley, President and Chief ...
Texas voters approved a generational investment into water infrastructure Tuesday night after approving an additional $20 ...
RWJBarnabas Health and SciTech Scity launch a pilot using Biobeat’s FDA-cleared cuffless blood pressure patch at Jersey City ...
Operator: Good morning, everyone. And welcome to the Abeona Therapeutics third quarter 2025 conference call. At this time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback